Form 4 for LFVN Lifevantage Corp
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-06 · accession 0001628280-25-051220 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | 2025-11-06 | LFVN | Dayton Judd | Dir | A - Grant | $7.76 | +13.5K | 47.2K | +40% | +$105.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-06 | A | A | 13,531 | $7.76 | 47,162 | D | — | — | (F1) These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date. (F2) The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant. |